{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:47:29Z","timestamp":1782244049069,"version":"3.54.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Break-even cost analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study uses a break-even cost-effectiveness model to assess whether enoxaparin is cost-effective for venous thromboembolism (VTE) prophylaxis in patients undergoing posterior lumbar fusion (PLF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A 7-day course of enoxaparin 40\u00a0mg daily was evaluated using average retail drug costs and literature-based treatment costs for symptomatic VTE. VTE rates after PLF at 2, 3\u20136, and 7\u201312 vertebral segments were identified in the TriNetX Diamond database (2018\u20132023) for patients without prophylaxis. A break-even model calculated the absolute risk reduction and number needed to treat (NNT) for cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The 7-day enoxaparin course cost $411.34, and treating a symptomatic VTE cost $20,461.32. The overall VTE rate was 0.49%; rates were 0.38% (2-segment), 0.65% (3\u20136 segments), and 2.7% (7\u201312 segments). Enoxaparin was cost-effective only for 7\u201312 segment fusions (NNT=50). Sensitivity analyses demonstrated cost-effectiveness for all PLF and 3\u20136 segment fusions if drug cost is \u2264$100.00, or for 2-segment fusions if \u2264$50.00. Alternatively, it is cost-effective if VTE treatment costs \u2265$100,000 (all PLF, 2-segment) or \u2265$75,000 (3\u20136 segments).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Enoxaparin is cost-effective for PLF of 7\u201312 segments but not for PLF of fewer than 7 segments. Lower drug costs or higher treatment costs could make prophylaxis cost-effective for PLF of fewer segments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bsd.0000000000002102","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:00:09Z","timestamp":1781784009000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Break-Even Cost Analysis for Venous Thromboembolism Prophylaxis in Posterior Lumbar Fusion Surgery"],"prefix":"10.1097","volume":"39","author":[{"given":"Avani A.","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler M.","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5671-2304","authenticated-orcid":false,"given":"Iyad S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"R1-20260623","first-page":"49","article-title":"Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors.","volume":"11","author":"Jones","year":"2023","journal-title":"Med Sci (Basel)"},{"key":"R2-20260623","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.wneu.2011.12.089","article-title":"Venous thromboembolism after thoracic\/thoracolumbar spinal fusion","volume":"78","author":"Gephart","year":"2012","journal-title":"World Neurosurg"},{"key":"R3-20260623","doi-asserted-by":"crossref","first-page":"e5776","DOI":"10.1097\/MD.0000000000005776","article-title":"Factors predicting venous thromboembolism after spine surgery","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"suppl 2","key":"R4-20260623","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"R5-20260623","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2106\/JBJS.J.01759","article-title":"Incidence of symptomatic venous thromboembolism after elective knee arthroscopy","volume":"94","author":"Maletis","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R6-20260623","doi-asserted-by":"crossref","first-page":"e0015","DOI":"10.2106\/JBJS.OA.18.00015","article-title":"The rate of venous thromboembolism before and after spine surgery as determined with indirect multidetector CT","volume":"3","author":"Inoue","year":"2018","journal-title":"JB JS Open Access"},{"issue":"suppl 1","key":"R7-20260623","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1177\/2192568219858307","article-title":"Venous thromboprophylaxis in spine surgery","volume":"10","author":"Alvarado","year":"2020","journal-title":"Global Spine J"},{"issue":"suppl 2","key":"R8-20260623","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"R9-20260623","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jamainternmed.2013.817","article-title":"Cost consideration in the clinical guidance documents of physician specialty societies in the United States","volume":"173","author":"Schwartz","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R10-20260623","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1177\/10711007221112922","article-title":"Cost-effective modeling of thromboembolic chemoprophylaxis for total ankle arthroplasty","volume":"43","author":"Martinazzi","year":"2022","journal-title":"Foot Ankle Int"},{"key":"R11-20260623","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0149-2918(02)80091-1","article-title":"Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States","volume":"24","author":"Botteman","year":"2002","journal-title":"Clin Ther"},{"key":"R12-20260623","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1177\/03635465221130990","article-title":"Venous thromboembolism chemoprophylaxis in knee arthroscopy: a break-even analysis of cost","volume":"50","author":"Martinazzi","year":"2022","journal-title":"Am J Sports Med"},{"key":"R13-20260623","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jse.2023.09.032","article-title":"Venous thromboembolism prophylaxis in shoulder surgery: a break-even cost-effectiveness study","volume":"33","author":"Martinazzi","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"key":"R14-20260623","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jse.2016.07.071","article-title":"The cost effectiveness of vancomycin for preventing infections after shoulder arthroplasty: a break-even analysis","volume":"26","author":"Hatch","year":"2017","journal-title":"J Shoulder Elbow Surg"},{"key":"R15-20260623","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jse.2021.03.136","article-title":"Cost-utility analysis of total shoulder arthroplasty: a prospective health economic study using real-world data","volume":"30","author":"Grobet","year":"2021","journal-title":"J Shoulder Elbow Surg"},{"key":"R16-20260623","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.arthro.2016.01.063","article-title":"Cost-effectiveness of reverse total shoulder arthroplasty versus arthroscopic rotator cuff repair for symptomatic large and massive rotator cuff tears","volume":"32","author":"Makhni","year":"2016","journal-title":"Arthroscopy"},{"key":"R17-20260623","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199807093390204","article-title":"Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery","volume":"339","author":"Agnelli","year":"1998","journal-title":"N Engl J Med"},{"key":"R18-20260623","doi-asserted-by":"crossref","first-page":"11834","DOI":"10.1038\/srep11834","article-title":"Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study","volume":"5","author":"Yang","year":"2015","journal-title":"Sci Rep"},{"key":"R19-20260623","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"Grosse","year":"2016","journal-title":"Thromb Res"},{"key":"R21-20260623","doi-asserted-by":"crossref","first-page":"100295","DOI":"10.1016\/j.xnsj.2023.100295","article-title":"Chemical prophylaxis and venous thromboembolism following elective spinal surgery: a systematic review and meta-analysis","volume":"17","author":"Rahmani","year":"2024","journal-title":"North American Spine Society Journal (NASSJ)"},{"key":"R22-20260623","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/2192568218797094","article-title":"Risk factors for postoperative venous thromboembolic events in patients undergoing lumbar spine surgery","volume":"9","author":"Nazareth","year":"2019","journal-title":"Global Spine J"},{"key":"R23-20260623","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1177\/21925682231173642","article-title":"Venous thromboembolism rates have not decreased in elective lumbar fusion surgery from 2011 to 2020","volume":"14","author":"Ngan","year":"2024","journal-title":"Global Spine J"},{"key":"R24-20260623","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3171\/2010.9.SPINE10151","article-title":"Comparison of ICD-9-based, retrospective, and prospective assessments of perioperative complications: assessment of accuracy in reporting","volume":"14","author":"Campbell","year":"2011","journal-title":"J Neurosurg Spine"},{"key":"R25-20260623","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2106\/JBJS.L.01602","article-title":"Venous Thromboembolic events after spinal fusion: which patients are at high risk?","volume":"96","author":"Goz","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"R26-20260623","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.spinee.2017.10.013","article-title":"Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery","volume":"18","author":"McLynn","year":"2018","journal-title":"Spine J"},{"key":"R27-20260623","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archsurg.141.8.790","article-title":"The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials","volume":"141","author":"Leonardi","year":"2006","journal-title":"Arch Surg"},{"key":"R28-20260623","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3171\/2014.6.SPINE13447","article-title":"Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article","volume":"21","author":"Cox","year":"2014","journal-title":"J Neurosurg Spine"},{"key":"R29-20260623","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.wneu.2017.05.050","article-title":"Prevention of thromboembolic complications after spine surgery by the use of low-molecular-weight heparin","volume":"104","author":"Zeng","year":"2017","journal-title":"World Neurosurg"},{"key":"R30-20260623","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00007632-199604010-00016","article-title":"Deep vein thrombosis after major reconstructive spinal surgery","volume":"21","author":"Rokito","year":"1996","journal-title":"Spine (Phila Pa 1976)"}],"container-title":["Clinical Spine Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000002102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:01:54Z","timestamp":1782241314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bsd.0000000000002102","relation":{},"ISSN":["2380-0186","2380-0194"],"issn-type":[{"value":"2380-0186","type":"print"},{"value":"2380-0194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"2025-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}